Yoonsun Mo, M.S., Pharm.D., BCPS, BCCCP
Associate Professor of Pharmacy Practice
Division of Pharmacy Practice Yoonsun.Mo@liu.edu
Doctor of Pharmacy/ Master of Sciences in Pharmaceutical Sciences (Dual Degree program), Creighton University, Omaha, Nebraska
PGY-1 Pharmacy Resident, Barnes-Jewish Hospital, Saint Louis, Missouri
PGY-2 Critical Care Pharmacy Resident, University of Washington Medical Center/ Harborview Medical Center, Seattle, Washington
After post-graduate training, Dr. Mo started her career as a surgical/trauma intensive care unit (ICU) clinical pharmacist at Cedars-Sinai Medical Center in Los Angeles, California. During this time she served as adjunct assistant professor at the University of California, San Francisco (UCSF). Dr. Mo then joined the faculty at Western New England University College of Pharmacy (WNECOP) in Springfield, Massachusetts and served as an ICU clinical pharmacy specialist at Mercy Medical Center where she developed and established pharmacy services in the ICU. While at WNE, she was actively involved in research, scholarship, service, and education of doctor of pharmacy students. Dr. Mo came to LIU Pharmacy as associate professor in the fall of 2016. She is currently practicing in the medical ICU and precepting APPE pharmacy students at Brookdale University Hospital and Medical Center in Brooklyn, New York. She is board certified in pharmacotherapy as well as critical care. Dr. Mo has authored a number of peer-reviewed publications and she is a member of American College of Clinical Pharmacy and Society of Critical Care Medicine.
Dr. Mo’s research has focused on the area of critical care medicine, including pain/sedation/delirium practices, anticoagulation/coagulation management, and infectious diseases. During her time at WNE, various types of manuscripts including review articles, a case report, and an original research article have been published in well-reputed journals. With financial contributions from the College through internal Faculty Research grant, she has completed a large-scale, multidisciplinary, online survey study regarding delirium practices in the ICU. Additionally, she has conducted two research projects in collaboration with the ICU physicians. One of them, a multicenter, retrospective cohort study regarding continuous lidocaine infusion as adjunctive analgesia, has been submitted for publication. The other retrospective study evaluating the effect of modafinil on cognitive functions in ICU patients is currently in progress. Dr. Mo has a strong passion for clinical research and she enjoys mentoring pharmacy students pursuing ICU-related research projects.
Mo Y, Nehring F, Jung AH, Housman ST. Possible Hepatotoxicity Associated With Daptomycin: A Case Report and Literature Review. J Pharm Pract. 2016;29:253-6.
Mo Y, Zimmermann AE, Thomas MC. Practice Patterns and Opinions on Current Clinical Practice Guidelines Regarding the Management of Delirium in the Intensive Care Unit. J Pharm Pract. 2016 Jan 13. pii: 0897190015625396.
Mo Y, Thomas MC, Karras GE Jr. Barbiturates for the treatment of alcohol withdrawal syndrome: A systematic review of clinical trials. J Crit Care. 2016;32:101-7.
Mo Y, Scheer C, Abdallah GT. Emerging Role of Melatonin and Melatonin Receptor Agonists in Sleep and Delirium in Intensive Care Unit Patients. J Intensive Care Med. 2016;31:451-5.
Mo Y, Yam FK. Rational Use of Second-Generation Antipsychotics for the Treatment of ICU Delirium: A Neuropharmacological Approach. Journal of Pharmacy Practice. 2015 Jun 1. pii: 0897190015585763.
Mo Y, Yam FK. Recent Advances in the Development of Specific Antidotes for Target-Specific Oral Anticoagulant. Pharmacotherapy. 2015;35:198-207.
Mo Y, Zimmermann AE. Role of dexmedetomidine for the prevention and treatment of delirium in intensive care unit patients. Ann Pharmacother. 2013;47: 869-876.
Join the LIU Community!
We can't wait to welcome you to Shark Nation.
The application process is quick and easy, but if you have
any questions, our admissions counselors are here to help.